Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy
Conditions
Rheumatic Diseases · Rheumatoid Arthritis (RA) · Giant Cell Arteritis (GCA) · Psoriatic Arthritis (PsA) · Axial Spondylarthritis (axSpA) · Polymyalgia Rheumatica (PMR) · ANCA Associated Vasculitis (AAV) · Connective Tissue Disease (CTD) · Systemic Sclerosis (SSc) · Systemic Lupus Erthematosus (SLE) · Idiopathic Inflammatory Myopathy (IIM) · Autoinflammatory Disease · Gout Arthritis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University Hospital, Bonn, Bonn, North Rhine-Westphalia, Germany
Contact: Study coordinator (Valentin S. Schäfer, MD) · valentin.schaefer@ukbonn.de · 0049 228 287 17016Contact: Study coordinator (Simon M. Petzinna, MD) · Simon_Michael.Petzinna@ukbonn.de · 0049 151 582 337 07Contact: Principal Investigator (Valentin S. Schäfer, MD)Simon M. Petzinna, MD (Sub-investigator)